Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: a possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Neuropharmacology

• Publication date

  2010-06-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neuropharm.2010.02.016PMID 20193696PMCID PMC2849927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Presynaptic regulation of dopamine transmission in schizophrenia.

  2011cited by this paper
• Sensorimotor gating in neurotensin-1 receptor null mice.

  2010cited by this paper
• NT79: A novel neurotensin analog with selective behavioral effects.

  2010cited by this paper
• Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.

  2009influential reference
• Neurotensin receptors as modulators of glutamatergic transmission.

  2008cited by this paper
• Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice.

  2008cited by this paper
• Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment.

  2007cited by this paper
• Neurotensin type 2 receptor is involved in fear memory in mice

  2007cited by this paper
• Modulation of Amphetamine-Induced Dopamine Release by Group II Metabotropic Glutamate Receptor Agonist LY354740 in Non-Human Primates Studied with Positron Emission Tomography

  2006cited by this paper
• Detection of d-Serine in rat brain by capillary electrophoresis with laser induced fluorescence detection.

  2005influential reference
• D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia.

  2005cited by this paper
• Neurotensin-Deficient Mice Have Deficits in Prepulse Inhibition: Restoration by Clozapine but Not Haloperidol, Olanzapine, or Quetiapine

  2005cited by this paper
• Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.

  2005cited by this paper
• Effects of l-Stepholidine on Forebrain Fos Expression: Comparison with Clozapine and Haloperidol

  2005cited by this paper
• Specific involvement of neurotensin type 1 receptor in the neurotensin‐mediated in vivo dopamine efflux using knock‐out mice

  2004cited by this paper
• Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.

  2003cited by this paper
• Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment.

  2003cited by this paper
• Glutamate, Dopamine, and Schizophrenia

  2003cited by this paper
• The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin.

  2002cited by this paper
• Enhanced Neurotensin Neurotransmission Is Involved in the Clinically Relevant Behavioral Effects of Antipsychotic Drugs: Evidence from Animal Models of Sensorimotor Gating

  2001cited by this paper
• Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.

  2001cited by this paper
• Neurotensin-deficient mice show altered responses to antipsychotic drugs

  2001cited by this paper
• On the mechanism of d‐amphetamine‐induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats

  2000cited by this paper
• Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: involvement of high affinity transporter mechanisms.

  1999cited by this paper
• The K‐Opioid Agonist, U‐69593, Decreases Acute Amphetamine‐Evoked Behaviors and Calcium‐Dependent Dialysate Levels of Dopamine and Glutamate in the Ventral Striatum

  1999influential reference
• Endogenous Dopamine Increases Extracellular Concentrations of Glutamate and GABA in Striatum of the Freely Moving Rat: Involvement of D1 and D2 Dopamine Receptors

  1999cited by this paper
• Does neurotensin mediate the effects of antipsychotic drugs?

  1999cited by this paper
• Amphetamine releases GABA in striatum of the freely moving rat: involvement of calcium and high affinity transporter mechanisms.

  1998cited by this paper
• The 100-kDa Neurotensin Receptor Is gp95/Sortilin, A Non-G-Protein-coupled Receptor*

  1998cited by this paper
• CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder.

  1997cited by this paper
• Structure, Functional Expression, and Cerebral Localization of the Levocabastine-Sensitive Neurotensin/Neuromedin N Receptor from Mouse Brain

  1996cited by this paper
• Ketamine activates psychosis and alters limbic blood flow in schizophrenia

  1995cited by this paper
• CSF concentrations of neurotensin in schizophrenia: an investigation of clinical and biochemical correlates.

  1994cited by this paper
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994cited by this paper
• Dopamine receptor antagonist blocks the release of glycine, GABA, and taurine produced by amphetamine.

  1993cited by this paper
• Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor

  1993cited by this paper
• Dopaminergic Modulation of Glutamate Release in Striatum as Measured by Microdialysis

  1992cited by this paper
• Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients.

  1991cited by this paper
• The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia.

  1986cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.

  1980cited by this paper
• Neurotensin: perchance an endogenous neuroleptic?

  1980cited by this paper

• Physiological and Pathological Roles of NTSR2 in Several Organs and Diseases (Review).

  2023cites this paper
• Neurotensin/Neuromedin N

  2020cites this paper
• Identification of Neurotensin Receptor Expressing Cells in the Ventral Tegmental Area across the Lifespan

  2018cites this paper
• Animal Models: Citations

  2016cites this paper
• Elucidating the Role of Neurotensin in the Pathophysiology and Management of Major Mental Disorders

  2014cites this paper
• Diverse Roles of Neurotensin Agonists in the Central Nervous System

  2013cites this paper
• Long term compulsivity on the 5-choice serial reaction time task after acute Chlorpyrifos exposure.

  2013cites this paper
• Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2.

  2011cites this paper
• The role of neurotensin in physiologic and pathologic processes

  2011cites this paper
• Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophrenia.

  2010cites this paper
• Effects of neurotensin-2 receptor deletion on sensorimotor gating and locomotor activity.

  2010cites this paper